Druggability Technologies (DRGT), of Dublin, said it entered a multiyear collaboration with Bayer HealthCare, of Leverkusen, Germany, to deploy DRGT’s Super-API platform in support of Bayer’s formulation efforts directed at improving compound solubility and bioavailability.